Journal of the Neurological Sciences 1998-10-01

SR57746A: a survival factor for motor neurons in vivo.

Y Iwasaki, T Shiojima, M Kinoshita, K Ikeda

Index: J. Neurol. Sci. 160 Suppl 1 , S92-6, (1998)

Full Text: HTML

Abstract

SR57746A(1-[2-(naphth-2-yl)ethy]]-4-(3-trifluoromethyl phenyl)-1,2,5,6-tetrahydropyridine, hydrochloride) is a non-peptide compound which has been shown to exhibit a wide range of neurotrophic effects both in vitro and in vivo. Here we examine the ability of SR57746A on axotomized spinal motor neuron death in the developing rat spinal cord. After postnatal unilateral section of rat sciatic nerve, there was approximately a 50% survival of motor neurons in the fourth lumbar segment (L4). Intraperitoneal injection of SR57746A for consecutive 14 days rescued motor neuron death but did not preserve the motor neuron diameter both on axotomy and non-axotomy side. These results suggest that SR57746A is a survival factor for motor neurons in vivo and may serve as therapeutic agent for damaged motor neurons.


Related Compounds

Related Articles:

5-HT1A receptors are involved in the effects of xaliproden on G-protein activation, neurotransmitter release and nociception.

2009-09-01

[Br. J. Pharmacol. 158(1) , 232-42, (2009)]

Magnetic resonance imaging of the neuroprotective effect of xaliproden in rats.

2002-06-01

[Invest. Radiol. 37(6) , 321-7, (2002)]

The neuroprotective agent SR 57746A abrogates experimental autoimmune encephalomyelitis and impairs associated blood-brain barrier disruption: implications for multiple sclerosis treatment.

1999-10-26

[Proc. Natl. Acad. Sci. U. S. A. 96(22) , 12855-9, (1999)]

Administration of amyloid beta-peptides in the rat medial septum causes memory deficits: reversal by SR 57746A, a non-peptide neurotrophic compound.

1996-08-02

[Neurosci. Lett. 213(2) , 79-82, (1996)]

The non-peptide neuroprotective agents SR 57746A interacts with neurotrophin 3 to induce differentiation in the PC12 cell-line.

1998-03-01

[J. Pharm. Pharmacol. 50(3) , 323-7, (1998)]

More Articles...